The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors

Arthritis Research and Therapy

Volumn 9, Issue 6, 2007, Pages

  de Rham, Casimir ^a   Ferrari Lacraz, Sylvie ^a   Jendly, Sabrina ^a   Schneiter, Gregory ^a   Dayer, Jean Michel ^a   Villard, Jean ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 21; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN P44; AUTACOID; CYTOKINE; IL2 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN DERIVATIVE; NCR2 PROTEIN, HUMAN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALLOIMMUNITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; AUTOIMMUNITY; CELL MATURATION; CELL TRANSPLANTATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; EX VIVO STUDY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOTHERAPY; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MOLECULAR RECOGNITION; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PHENOTYPIC VARIATION; PROTEIN EXPRESSION; T LYMPHOCYTE; BIOSYNTHESIS; CELL PROLIFERATION; CLASSIFICATION; CYTOLOGY; CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; GENETICS; IMMUNOLOGY; IN VITRO STUDY; METABOLISM;

CELL PROLIFERATION; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DRUG SYNERGISM; HUMANS; INFLAMMATION MEDIATORS; INTERFERON TYPE II; INTERLEUKIN-15; INTERLEUKIN-2; INTERLEUKINS; KILLER CELLS, NATURAL; RECEPTORS, IMMUNOLOGIC; RECEPTORS, KIR; RECOMBINANT PROTEINS;

EID: 37749035317     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2336     Document Type: Article

References (43)

1. Parham P MHC class I molecules and KIRs in human history, health and survival Nat Rev Immunol 2005, 5:201-214. 10.1038/nri1570 15719024
2. Shi FD Van Kaer L Reciprocal regulation between natural killer cells and autoreactive T cells Nat Rev Immunol 2006, 6: 751-760. 10. 1038/nri1935 16998508
3. Lanier LL NK cell recognition Annu Rev Immunol 2005, 23:225-274. 10.15771571
4. Uhrberg M Valiante NM Shum BP Shilling HG Lienert-Weidenbach K Corliss B Human diversity in killer cell inhibitory receptor genes Immunity 1997, 7:753-763. 10.1016/S1074-7613(00)80394-5 9430221
5. Hsu KC Chida S Geraghty DE Dupont B The killer cell immunoglobulin-like receptor (KIR) genomic region: Gene-order, haplotypes and allelic polymorphism Immunol Rev 2002, 190:40-52. 10.1034/ j.1600-065X.2002.19004.x 12493005
6. Cooper MA Fehniger TA Turner SC Chen KS Ghaheri BA Ghayur T Carson WE Caligiuri MA Human natural killer cells: A unique innate immunoregulatory role for the CD56(bright) subset Blood 2001, 97:31-46. 3151 10.1182/blood.V97.10.3146 11342442
7. Long EO Regulation of immune responses through inhibitory receptors Annu Rev Immunol 1999, 17:875-904. 10.1146/annurev.immunol.17.1.875 10358776
8. Biassoni R Cantoni C Pende D Sivori S Parolini S Vitale M Bottino C Moretta A Human natural killer cell receptors and co-receptors Immunol Rev 2001, 181:203-214. 10.1034/j.1600-065X.2001.1810117.x 11513142
9. Colucci F Caligiuri MA Di Santo JP What does it take to make a natural killer? Nat Rev Immunol 2003, 3:413-425. 10.1038/nri1088 12766763
10. Ruggeri L Capanni M Urbani E Perruccio K Shlomchik WD Tosti A Posati S Rogaia D Frassoni F Aversa F Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 2002, 295:2097-2100. 10.1126/science.1068440 11896281
11. Ruggeri L Capanni M Casucci M Volpi I Tosti A Perruccio K Urbani E Negrin RS Martelli MF Velardi A Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation Blood 1999, 94:333-339. 10381530
12. Ruggeri L Mancusi A Capanni M Urbani E Carotti A Aloisi T Stern M Pende D Perruccio K Burchielli E Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: Challenging predictive value Blood 2007, 110:433-440, 10.1182/blood-2006-07-038687 17371948
13. Murphy WJ Koh CY Raziuddin A Bennett M Longo DL Immunobiology of natural killer cells and bone marrow transplantation: Merging of basic and preclinical studies Immunol Rev 2001, 181:279-289. 10.1034/ j.1600-065X.2001.1810124.x 11513149
14. Miller JS Soignier Y Panoskaltsis-Mortari A McNearney SA Yun GH Fautsch SK McKenna D Le C Defor TE Burns LJ Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer Blood 2005, 105:3051-3057. 10.1182/blood-2004-07-2974 15632206
15. Liu R Van Kaer L La Cava A Price M Campagnolo DI Collins M Young DA Vollmer TL Shi FD Autoreactive T cells mediate NK cell degeneration in autoimmune disease J Immunol 2006, 176:5247-5254. 16621990
16. Fehniger TA Caligiuri MA Interleukin 15: Biology and relevance to human disease Blood 2001, 97:14-32. 10.1182/blood.V97.1.14 11133738
17. Loza MJ Perussia B The IL-12 signature: NK cell terminal CD56+high stage and effector functions J Immunol 2004, 172:88-96. 14688313
18. Gays F Martin K Kenefeck R Aust JG Brooks CG Multiple cytokines regulate the NK gene complex-encoded receptor repertoire of mature NK cells and T cells J Immunol 2005, 175:2938-2947. 16116180
19. Lyons AB Parish CR Determination of lymphocyte division by flow cytometry J Immunol Methods 1994, 171:131-137. 10.1016/ 0022-1759(94)90236-4 8176234
20. Kasaian MT Whitters MJ Carter LL Lowe LD Jussif JM Deng B Johnson KA Witek JS Senices M Konz RF IL-21 limits NK cell responses and promotes antigen-specific T cell activation: A mediator of the transition from innate to adaptive immunity Immunity 2002, 16:559-569. 10.1016/ S1074-7613(02)00295-9 11970879
21. Moretta A Bottino C Vitale M Pende D Cantoni C Mingari MC Biassoni R Moretta L Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis Annu Rev Immunol 2001, 19:197-223. 10.1146/annurev.immunol.19.1.197 11244035
22. Cantoni C Bottino C Vitale M Pessino A Augugliaro R Malaspina A Parolini S Moretta L Moretta A Biassoni R NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily J Exp Med 1999, 189:787-796. 10.1084/jem.189.5.787 10049942
23. Moretta L Biassoni R Bottino C Mingari MC Moretta A Human NK-cell receptors Immunol Today 2000, 21:420-422. 10.1016/S0167-5699(00)01673-X 10953091
24. Burgess SJ Marusina AI Pathmanathan I Borrego F Coligan JE IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells J Immunol 2006, 176:1490-1497. 16424177
25. Takaki R Watson SR Lanier LL DAP12: An adapter protein with dual functionality Immunol Rev 2006, 214:118-129. 10.1111/ j.1600-065X.2006.00466.x 17100880
26. Li Z Lim WK Mahesh SP Liu B Nussenblatt RB Cutting edge: In vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis J Immunol 2005, 174:5187-5191. 15843513
27. Becknell B Caligiuri MA Interleukin-2, interleukin-15, and their roles in human natural killer cells Adv Immunol 2005, 86:209-239. 10.1016/ S0065-2776(04)86006-1 15705423
28. Leonard WJ Spolski R Interleukin-21: A modulator of lymphoid proliferation, apoptosis and differentiation Nat Rev Immunol 2005, 5:688-698. 10.1038/nri1688 16138102
29. Rosenberg SA Interleukin-2 and the development of immunotherapy for the treatment of patients with cancer Cancer J Sci Am 2000, Suppl 1:S2-S7.
30. Farag SS Caligiuri MA Cytokine modulation of the innate immune system in the treatment of leukemia and lymphoma Adv Pharmacol 2004, 51:295-318. 15464915
31. Curti BD Immunomodulatory and antitumor effects of interleukin-21 in patients with renal cell carcinoma Expert Rev Anticancer Ther 2006, 6:905-909. 10.1586/14737140.6.6.905 16761934
32. Igarashi T Wynberg J Srinivasan R Becknell B McCoy JP Jr Takahashi Y Suffredini DA Linehan WM Caligiuri MA Childs RW Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells Blood 2004, 104:170-177. 10.1182/blood-2003-12-4438 15016654
33. Koehl U Esser R Zimmermann S Tonn T Kotchetkov R Bartling T Sörensen J Grüttner HP Bader P Seifried E Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children Klin Padiatr 2005, 217:345-350. 10.1055/ s-2005-872520 16307421
34. Passweg JR Stern M Koehl U Uharek L Tichelli A Use of natural killer cells in hematopoetic stem cell transplantation Bone Marrow Transplant 2005, 35:637-643. 10.1038/sj.bmt.1704810 15654351
35. Ljunggren HG Malmberg KJ Prospects for the use of NK cells in immunotherapy of human cancer Nat Rev Immunol 2007, 7:329-339. 10.1038/ nri2073 17438573
36. Chiossone L Vitale C Cottalasso F Moretti S Azzarone B Moretta L Mingari MC Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: Evidence for different susceptibility of IL-2-versus IL-15-activated NK cells Blood 2007, 109:3767-3775. 10.1182/ blood-2006-07-037846 17234744
37. Parrish-Novak J Dillon SR Nelson A Hammond A Sprecher C Gross JA Johnston J Madden K Xu W West J Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function Nature 2000, 408:57-63. 10.1038/35040504 11081504
38. Sivori S Cantoni C Parolini S Marcenaro E Conte R Moretta L Moretta A IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors Eur J Immunol 2003, 33:3439-3447. 10.1002/eji.200324533 14635054
39. Alves NL Arosa FA van Lier RA IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells J Immunol 2005, 175:755-762. 16002671
40. Valiante NM Uhrberg M Shilling HG Lienert-Weidenbach K Arnett KL D'Andrea A Phillips JH Lanier LL Parham P Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors Immunity 1997, 7:739-751. 10.1016/S1074-7613(00)80393-3 9430220
41. Saleh A Davies GE Pascal V Wright PW Hodge DL Cho EH Lockett SJ Abshari M Anderson SK Identification of probabilistic transcriptional switches in the Ly49 gene cluster: A eukaryotic mechanism for selective gene activation Immunity 2004, 21:55-66. 10.1016/j.immuni.2004.06.005 15345220
42. Bakker AB Hoek RM Cerwenka A Blom B Lucian L McNeil T Murray R Phillips LH Sedgwick JD Lanier LL DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming Immunity 2000, 13:345-353. 10.1016/S1074-7613(00)00034-0 11021532
43. Bielekova B Catalfamo M Reichert-Scrivner S Packer A Cerna M Waldmann TA McFarland H Henkart PA Martin R Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis Proc Natl Acad Sci USA 2006, 103:5941-5946. 1458677 16585503 10.1073/pnas.0601335103